Higher DHX9 expression was observed in MDS patients compared with the control individuals and associated with poor survival and high AML transformation, suggesting the potential role of DHX9 as an oncogene in promoting clonal proliferation in MDS. This evidence concerns the gene DHX9 and acute myeloid leukemia.